×
About 362 results
ISTALOL® (timolol maleate ophthalmic solution)
http://www.bausch.com/our-products/rx-pharmaceutical/istalol-timolol-maleate-ophthalmic-solution-05

In a well controlled, double-masked, parallel study of 332 patients with untreated intraocular pressures of 22 mm Hg or greater, Istalol administered once daily (AM) was equivalent to timolol maleate ophthalmic solution 0.5% administered twice daily.1 In both groups, mean intraocular pressure decreased from 25 mm Hg at ...

LUMIGAN® (bimatoprost ophthalmic solution)
http://www.lumigan.com/

LUMIGAN® 0.01% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution)
https://www.combigan.com/hcp/

COMBIGAN® is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP.

ALPHAGAN® P (brimonidine tartrate ophthalmic solution)
http://alphaganp.com/hcp/siteindex.aspx

ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% or 0.15% is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

AZOPT® (brinzolamide ophthalmic suspension) 1%
http://www.myglaucomasupport.com/explore-treatments/azopt-suspension.shtml

AZOPT ® Suspension is a carbonic anhydrase inhibitor (CAI) indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or ...

COSOPT® PF (dorzolamide hydrochloride-timolol maleate ophthalmic solution)
http://www.akorn.com/prod_detail.php?ndc=17478-604-30

COSOPT PF is a carbonic anhydrase inhibitor with a beta-adrenergic receptor blocking agent indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.

RHOPRESSA® (netarsudil ophthalmic solution)
https://rhopressa.com/hcp/

Rhopressa (netarsudil ophthalmic solution) 0.02% is a once-daily Rho-associated protein kinase (ROCK) inhibitor approved by the FDA for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. See full Prescribing and Safety Information.

TRAVATAN Z OPHTHALMIC SOLUTION (travoprost ophthalmic solution)
http://www.myglaucomasupport.com/explore-treatments/travatan-z-solution.shtml

TRAVATAN Z ® (travoprost ophthalmic solution) 0.004% is a once-a-day eye drop you take in the evening to help reduce the elevated pressure inside your eye. It belongs to a class of drugs called prostaglandin analogs. These drugs work by increasing the drainage of fluid inside the eye. They help fluid exit the eye through ...

Rocklatan™ (netarsudil/latanoprost ophthalmic solution)
https://rocklatan.com/hcp/

ROCKLATAN™ (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% is a fixed combination of a Rho kinase inhibitor and a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

XELPROS™ (latanoprost ophthalmic emulsion) 0.005%, for topical ophthalmic use Prescribing Information
https://xelpros.com/

XELPROS™, a prescription treatment for the treatment of open-angle glaucoma or ocular hypertension, is now available.

SIMBRINZA® (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2%
http://www.myglaucomasupport.com/simbrinza-suspension.shtml

Learn more about SIMBRINZA® (brinzolamide/ brimonidine tartrate ophthalmic suspension) 1%/0.2% at myalcon.com.

VYZULTA (latanoprostene bunod ophthalmic solution)
https://www.vyzulta.com/hcp/

VYZULTA DELIVERS A DUAL MECHANISM OF ACTION. FOR THE REDUCTION OF IOP IN GLAUCOMA Patients1. Vyzulta Banner. One molecule. TWO OUTFLOW PATHWAYS. PROVEN IOP Reduction.1-3*. *In studies up to 12 months' duration, the IOP-lowering effect was up to 7.5 to 9.1 mmHg, in patients with an

Xalatan® (latanoprost ophthalmic solution)
https://www.pfizerpro.com/product/xalatan/hcp

XALATAN® (latanoprost ophthalmic solution) is contraindicated in patients with ... It has been shown that administration of these prostaglandin drug products ...

Mannitol - mannitol injection, solution-General Injectables & Vaccines, Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8fd5c06-0f71-4699-8c5b-1a8868cb7da2

Jan 12th, 2020 - Mannitol intravenous (Mannitol Injection, USP) is indicated for the following purposes in adults and pediatric patients. Therapeutic Use Reduction of intracranial pressure and brain mass. Reduction of high intraocular pressure when the pressure cannot be lowered by other means. Diagnostic Use Measurement of glomerular filtration rate.

Mannitol - mannitol injection, solution-ICU Medical Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba7bf864-8a4d-4262-8fd1-00174fa2f9d1

Jan 6th, 2020 - Mannitol Intravenous (Mannitol Injection, USP) is indicated for the following purposes in adults and pediatric patients. Therapeutic Use Reduction of intracranial pressure and brain mass. Reduction of high intraocular pressure when the pressure cannot be lowered by other means. Diagnostic Use Measurement of glomerular filtration rate.

Acetazolamide - acetazolamide tablet-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=268db224-d5db-457c-86bc-972c9fe07917

Jan 5th, 2020 - For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide Tablets are also indicated for the prevention or a...

Dorzolamide hydrochloride and timolol maleate - dorzolamide hydrochloride and timolol maleate solution/ drops-Golden State Medical Supply, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5c104e7-4d99-49ec-80bf-eccea69b4c79

Jan 2nd, 2020 - Dorzolamide hydrochloride-timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to betablockers (failed to achieve target IOP determined after multiple measurements over time). The IOP-lowering of dorzolamide hydrochloride-timolol maleate ophthalmic s...

Pilocarpine hydrochloride - pilocarpine hydrochloride ophthalmic solution solution/ drops-Somerset Therapeutics, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84428e9a-f486-44d9-ad93-4ea9069a6787

Dec 27th, 2019 - Pilocarpine hydrochloride ophthalmic solution, is indicated for the: Pilocarpine hydrochloride ophthalmic solution, USP is a muscarinic cholinergic agonist indicated for The reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (1.1) The management of acute angle-closure glaucoma (1.2) The prevention of postoperative elevated IOP associated...

Dorzolamide hydrochloride - dorzolamide hydrochloride solution/ drops-Hi-Tech Pharmacal Co., Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95fe7c85-b0e1-420d-8128-fd9e7a1fed09

Dec 26th, 2019 - Dorzolamide hydrochloride ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Dorzolamide hydrochloride is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. (1)

Travoprost ophthalmic solution usp, 0.004% travoprost - travoprost ophthalmic solution usp, 0.004% solution/ drops-Alembic Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be3bdc10-b5eb-4b4b-9a00-1f8c03ccb3b5

Dec 19th, 2019 - Travoprost Ophthalmic Solution USP, 0.004% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Travoprost Ophthalmic Solution USP, 0.004% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.